March 21st, 2019
Sherlock Biosciences licenses Wyss technology to create affordable molecular diagnostics
Synthetic biology-based diagnostic platform enables low-cost, highly sensitive detection of nucleic acids in a wide range of settings
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
March 21st, 2019
Synthetic biology-based diagnostic platform enables low-cost, highly sensitive detection of nucleic acids in a wide range of settings
March 14th, 2019
Venture capitalists, executives and legal experts are a phone call away for innovative Harvard researchers
March 13th, 2019
Deerfield commits $100M to inject fuel into translational life science research at Harvard
March 8th, 2019
Early-stage drug-delivery projects become business plans at OTD’s Guppy Tank
February 27th, 2019
Innovations in sensors, voltage control, cortistatin analogues, anti-PD-L1 antibodies, assembly of nucleic acid sequences, light-emitting devices, acoustophoretic printing, and more